CloudMD Software & Services Inc
XTSX:DOC

Watchlist Manager
CloudMD Software & Services Inc Logo
CloudMD Software & Services Inc
XTSX:DOC
Watchlist
Price: 0.035 CAD Market Closed
Market Cap: 10.7m CAD

CloudMD Software & Services Inc
Investor Relations

CloudMD Software & Services, Inc. operates as an investment company with interests in healthcare and rehabilitation services. The company is headquartered in Vancouver, British Columbia and currently employs 224 full-time employees. The company went IPO on 2017-11-29. The company is focused on building one connected platform that addresses all points of a patient’s healthcare journey and provides access to care and outcomes. Through CloudMD’s technology, the Company delivers hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s Enterprise Health Solutions Division includes the student assistance program and employee assistance programs in Canada. The company offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to manage the health and wellness of their students, employees, and customers. The firm also provides employers with a connected, comprehensive platform to manage the health and wellness of their employees.

Show more
Loading
DOC
S&P TSX Composite Index (Canada)

Earnings Calls

2023 Q3
Nov 30, 2023
Show Transcript
Previous
Next
CloudMD Reports Positive Q3 with Strong Growth
2023 Q3
Nov 30, 2023

In Q3, CloudMD achieved $23.6 million in revenue, up 2% from the previous quarter with a leap to positive adjusted EBITDA of $49,000. This marks a key milestone as they hit profitability ahead of schedule, showing effective cost management and $21 million in annualized savings. The company signed $2.8 million in multiyear contracts, signaling confidence in sustained double-digit organic growth. A foundational remote patient monitoring contract estimated to generate $3-4 million per quarter is set to start contributing significantly by early 2024. Gross margin improved 150 basis points year-over-year despite a minor decline due to revenue mix shifts. Adjusted EBITDA rose remarkably from negative $3.2 million last year, with SG&A expenses down to 37% of revenue. Future prospects include continued margin expansion and cash flow positivity, with an ongoing disciplined capital strategy and share consolidation being considered to bolster market appeal.

Show Full Analysis

Management

Ms. Karen Adams M.D.
CEO, President, COO & Director
No Bio Available
Mr. John Plunkett C.A., CPA
EVP of Corporate Development & Integration
No Bio Available
Mr. Prakash Jayanti Patel CPA
Chief Financial Officer
No Bio Available
Mr. Dhruv Chandra
Chief Technology Officer
No Bio Available
Ms. Aida Begovic
Executive Vice President of Digital Health Solutions
No Bio Available
Mr. Jon Harju
Senior Vice President of Engineering
No Bio Available
Ms. Robin Cooper
Senior Vice President of Partnerships & Growth
No Bio Available
Mr. Bram Lowsky
Executive VP, Head of Health & Wellness Services and President of EHS
No Bio Available
Mr. Nathan Lane
Executive VP of Health & Productivity Solutions and US Operations
No Bio Available
Olga McRae
Corporate Secretary
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
810 - 789 West Pender Street
Contacts
+17783701413.0
investors.cloudmd.ca